Loratadine
Loratadine.JPG

Loratadine

CLINICAL USE

Antihistamine:Symptomatic relief of allergy such as hay fever, urticaria

DOSE IN NORMAL RENAL FUNCTION

10 mg daily

PHARMACOKINETICS

  • Molecular weight                           :382.9
  • %Protein binding                           :97–99
  • %Excreted unchanged in urine     : 40
  • Volume of distribution (L/kg)       :No data
  • half-life – normal/ESRD (hrs)      :12–15/Unchanged

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Not dialysed. Dose as in normal renal function
  • HD                     :Not dialysed. Dose as in normal renal function
  • HDF/high flux   :Unknown dialysability. Dose as in normal renal function
  • CAV/VVHD      :Unlikely to be dialysed. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • Antibacterials: concentration possibly increased by erythromycin
  • Antifungals: concentration of loratadine possibly increased by ketoconazole – avoid concomitant use
  • Antivirals: concentration possibly increased by amprenavir – avoid concomitant use; concentration possibly increased by ritonavir

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    OTHER INFORMATION

    Patients with renal impairment are at increased risk of sedation.



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs